Identification, monitoring and treatment of disease and...

Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C702S020000, C703S011000, C435S006120, C536S024100

Reexamination Certificate

active

07957909

ABSTRACT:
Gene expression data, in particular gene expression profiles, are created and used in the identification, monitoring and treatment of disease and characterization of biological conditions. Profile data sets are derived from subject samples and include quantitative substantially repeatable measures of a distinct amount of RNA or protein constituent in a panel selected to enable evaluation of a biological condition. Such profile data sets may be used to provide an index indicative of the biological state of a subject, which may be compared to a normative value of the index determined with respect to a relevant population of subjects.

REFERENCES:
patent: 5506145 (1996-04-01), Bull et al.
patent: 5643765 (1997-07-01), Willey
patent: 5696130 (1997-12-01), Jones et al.
patent: 5800992 (1998-09-01), Fodor et al.
patent: 5811231 (1998-09-01), Farr et al.
patent: 5846720 (1998-12-01), Foulkes et al.
patent: 5866330 (1999-02-01), Kinzier et al.
patent: 5882925 (1999-03-01), Falb et al.
patent: 5955269 (1999-09-01), Ghai et al.
patent: 5968784 (1999-10-01), Spinella et al.
patent: 5994076 (1999-11-01), Chenchik et al.
patent: 6022683 (2000-02-01), Poirier
patent: 6132969 (2000-10-01), Stoughton et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6150169 (2000-11-01), Smith et al.
patent: 6165709 (2000-12-01), Friend et al.
patent: 6185561 (2001-02-01), Balaban et al.
patent: 6203987 (2001-03-01), Friend et al.
patent: 6203988 (2001-03-01), Kambara et al.
patent: 6218122 (2001-04-01), Friend et al.
patent: 6222093 (2001-04-01), Marton et al.
patent: 6232065 (2001-05-01), Robinson et al.
patent: 6245517 (2001-06-01), Chen et al.
patent: 6309822 (2001-10-01), Fodor et al.
patent: 6309823 (2001-10-01), Cronin et al.
patent: 6960439 (2005-11-01), Bevilacqua et al.
patent: 2001/0018182 (2001-08-01), Friend et al.
patent: 2001/0029018 (2001-10-01), Danenberg et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0012932 (2002-01-01), Wang
patent: 2002/0045197 (2002-04-01), Friend et al.
patent: 9-503921 (1997-04-01), None
patent: 10-261029 (1998-09-01), None
patent: WO 94/23023 (1994-10-01), None
patent: WO 97/41261 (1997-06-01), None
patent: WO 98/24935 (1998-06-01), None
patent: WO98/24935 (1998-06-01), None
patent: WO-98/31838 (1998-07-01), None
patent: WO 99/04251 (1999-01-01), None
patent: WO 99/44063 (1999-02-01), None
patent: WO-9913113 (1999-03-01), None
patent: WO-99/23254 (1999-05-01), None
patent: WO 99/46403 (1999-09-01), None
patent: WO99/54510 (1999-10-01), None
patent: WO 99/54510 (1999-10-01), None
patent: WO 99/54510 (1999-10-01), None
patent: WO 99/11822 (1999-11-01), None
patent: WO 99/57130 (1999-11-01), None
patent: WO 99/58720 (1999-11-01), None
patent: WO 00/11208 (2000-02-01), None
patent: WO 00/22172 (2000-04-01), None
patent: WO 00/28092 (2000-05-01), None
patent: WO00/58728 (2000-10-01), None
patent: WO 00/71756 (2000-11-01), None
patent: WO 01/11082 (2001-02-01), None
patent: WO 01/12851 (2001-02-01), None
patent: WO 01/20998 (2001-03-01), None
patent: WO 01/23614 (2001-04-01), None
patent: WO 01/25473 (2001-04-01), None
patent: WO 01/27321 (2001-04-01), None
patent: WO 01/29261 (2001-04-01), None
patent: WO 01/29269 (2001-04-01), None
patent: WO 01/30972 (2001-05-01), None
patent: WO 01/32928 (2001-05-01), None
patent: WO 03/040404 (2003-05-01), None
Heller et al (PNAS, vol. 94, No. 6, p. 2150-2155, 1997: of record in U.S. Appl. No. 10/701,391).
Desjardin et al. (Journal of Clinical of Microbiology, vol. 36, No. 7, p. 1964-1968).
Schmittgen et al. (Journal of Biochemical and Biophysical Methods, vol. 46, p. 69-81,2000).
Heller et al. (PNAS, vol. 94, No. 6, p. 2150-2155, 1997).
Asthana, D., et al., Differential Effects of IFN-γ on Kidney Cell Expression of MHC Class II Molecules, Kidney Cell Associated Molecules and Their Stimulatory Capacity in Mixed Lymphocyte Kidney Cell Culture;Transpl Immunol, vol. 1, pp. 282-293; 1993.
Beasley, Ellen M., et al., “Statistical Refinement of Primer Design Parameters,” Academic Press, PCR Applications, 1999, pp. 59-71.
Beer, David G., et al., “Gene-Expression Profiles Predict Survival of Patients With Lung Adenocarcinoma,”Nature Medicine, Aug. 2002, vol. 8, No. 8, pp. 816-824.
Buchwald, D., et al., Markers of Inflammation and Immune Activation in Chronic Fatigue and Chronic Fatigue Syndrome;J Rheumatol, vol. 24, pp. 372-376; 1997.
Cheronis, J.C., et al., “Utility of High Precision QPCR in the Assessment of Anti-Inflammatory Drug Action,”Clinical Chemistry, vol. 28, No. 6, Supplement, Jun. 2002, p. A172.
Coenen, et al, “A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle”,Growth Hormone&IGF Research1999, 9, 179-186 Article No. ghir.1999.0104.
Cole, et al., “The Genetics of Cancer—A 3D Model,” Nature Genetics Supplement, vol. 21, Jan. 1999.
Eisenberg, et al., “Protein Function in the Post-Genomic Era,”Nature, vol. 405:823-826, Jun. 15, 2000.
Guan-Chiun Lee, et al, Analysis of the Gene Family Encoding Lipases incandid rugosaby Competitive Reverse Transcription-PCR,Applied and Environmental Microbiology, Sep. 1999, pp. 3888-3895.
Humbert, M., et al., Relationship Between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma;Am J Respir Crit Care Med, vol. 156, pp. 704-708, 1997.
Imai, S., et al., High Levels of Expression of Collagenase-3 (MMP-13) in Pathological Conditions Associated with a Foreign-Body Reaction;J Bone Joint Surg, vol. 80-B, pp. 701-710, Jul. 1998.
Jensen, et al, “Competitive reverse transcription polymerase chain reaction for quantifying pre-MRNA and mRNA of major acute phase proteins”,Journal of Immunological Methods, 215 (1998), pp. 45-58.
Kim, et al., “Strong Feature Sets from Small Samples”, Journal of Computational Biology, vol. 9, No. 1, 2002, Mary Ann Liebert, Inc. pp. 1127-1146.
Korenberg, “Prediction of Treatment Response Using Gene Expression Profiles”, Journal of Proteome Research 2002, 1, 55-61.
Lockhart, et al., “Genomics, Gene expression and DNA Arrays,”Nature, vol. 405:827-836, Jun. 15, 2000.
Loitsch, et al, “Reverse Transcription-Competitive Multiplex PCR Improves Quantification of mRNA in Clinical Samples—Application to the Low Abundance CFTR mRNA”,Clinical Chemistry45:5, (1999), pp. 619-624.
Mangalam, et al., “GeneX: An open source gene expression database and integrated tool set”, IBM Systems Journal, (2001), 40 (2), 552-569, 79 refs. ISSN: 0018-8670.
Meijers-Heijboer, M.D., et al., “Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation”, The New England Journal of Medicine, vol. 345:159-164, Jul. 19, 2001, No. 3.
Ono, K., et al., Cytokine Gene Expression After Myocardial Infarction in Rat Hearts (Possible Implication in Left Ventricular Remodeling);Circulationvol. 98, pp. 149-156, Jul. 14, 1998.
Pandey, et al. “Proteomics to Study Genes and Genomes,”Nature, vol. 405:837-846, Jun. 15, 2000.
Paradis, Valerie, et al. “Expression Profiling of Hepatocellular Carcinomas (HCC) Using a Large Scale Real-Time RT-PCR Approach: Determination of a Molecular Diagnostic Index,”Hepatology, vol. 36, No. 4, Part 2, Oct. 2002, p. 302A.
Rafalski, et al., “New experimental and computational approaches to the analysis of gene expression”, Acta Biochimica Polonica, vol. 45, No. 4/1998, 929-934.
Reinke, P., et al., “Immune Monitoring of Glucocorticoid Therapy,”Ernst Schering Research Foundation Workshop. Germany 2002, No. 40, pp. 25-37.
Risch, “Searching for Genetic Determinants in the New Millennium,”Nature, vol. 405:847-856, Jun. 15, 2000.
Rosenwald, M.D., et al, “The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma”, The New England Journal of Medicine, vol. 346:1937-1947, Jun. 20, 2002, No. 25.
Roses, “Pharmacogenetics and the Pratice of M

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Identification, monitoring and treatment of disease and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification, monitoring and treatment of disease and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification, monitoring and treatment of disease and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2684695

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.